Black Diamond Therapeutics (BDTX) Interest & Investment Income (2019 - 2021)
Historic Interest & Investment Income for Black Diamond Therapeutics (BDTX) over the last 3 years, with Q4 2021 value amounting to $588000.0.
- Black Diamond Therapeutics' Interest & Investment Income fell 5311.0% to $588000.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $3.6 million, marking a year-over-year decrease of 457.59%. This contributed to the annual value of $3.5 million for FY2021, which is 1427.86% down from last year.
- Per Black Diamond Therapeutics' latest filing, its Interest & Investment Income stood at $588000.0 for Q4 2021, which was down 5311.0% from $776000.0 recorded in Q3 2021.
- Black Diamond Therapeutics' 5-year Interest & Investment Income high stood at $1.3 million for Q4 2020, and its period low was $1000.0 during Q3 2019.
- Its 3-year average for Interest & Investment Income is $673222.2, with a median of $776000.0 in 2021.
- As far as peak fluctuations go, Black Diamond Therapeutics' Interest & Investment Income surged by 11610000.0% in 2020, and later tumbled by 5311.0% in 2021.
- Black Diamond Therapeutics' Interest & Investment Income (Quarter) stood at $440000.0 in 2019, then skyrocketed by 185.0% to $1.3 million in 2020, then tumbled by 53.11% to $588000.0 in 2021.
- Its Interest & Investment Income stands at $588000.0 for Q4 2021, versus $776000.0 for Q3 2021 and $948000.0 for Q2 2021.